Stay updated on T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial

Sign up to get notified when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer now identifies ClinicalTrials.gov as revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T23:17:25.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A notice about NIH’s website transition and its use of “Super Intelligence” terminology appears on the study record page.
    Difference
    0.6%
    Check dated 2026-10-25T22:43:05.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer's revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T22:58:33.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1. The study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-11T23:06:48.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 was added to the study record history, replacing the previous Revision: v3.6.6, signaling an updated version of the study record on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-09-20T20:36:17.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The record history page shows a new revision label v3.6.6 replacing the previous v3.6.5, indicating a deployment update rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-08-30T21:50:35.000Z thumbnail image

Stay in the know with updates to T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.